RT @kidney_boy: Ladies and gentleman, I think we have a therapy. https://t.co/QpN0tKFSfo https://t.co/WDCpgLwU0A
Probably u wre right @kidney_boy
@Trapouts I am not a doctor, I am not advocating in favor of either position. Here is a link to a study in the New England Journal of Medicine. It is worth noting that the sample size was small and the group was not compared with a placebo-controlled grou
RT @NHiro1118: 海外関係有りますかね❓アビガンは国産で軽症、中等症の患者に早期投薬すれば効果有りとの報告がある。
海外関係有りますかね❓アビガンは国産で軽症、中等症の患者に早期投薬すれば効果有りとの報告がある。
@hswapnil @abtahi_parvaneh @DFisman @ASPphysician @GermHunterMD @NIAIDNews so the other trial referenced is the 04/10 trail on compassionate use https://t.co/8DRiohwADs
RT @EricTopol: I'm feeling better that the signal I called weeks ago from the 1st report panned out to be true, despite many who challenged…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @CorinneReverbel: @dr_l_alexandre Phase grave: #Remdesivir marche pas https://t.co/Kt5GoRI98v + 23% des patients avec effets secondaire…
I feel hopeless day by day.
@Dr_Rajesh369 By uncontrolled study, I was referring to this: https://t.co/RcdjUpf9j5
①症例数が少ない②追跡期間が短い③データ不足を否定できない④ランダム化対照群との比較ではない https://t.co/BcPTOo1yr8
Compassionate Use of Remdesivir for Patients with Severe Covid-19 | NEJM https://t.co/z2PdEa1r4K
Compassionate Use of Remdesevir for Patients With Severe Covid-19. Article in the New England Journal of Medicine. https://t.co/B0hMZoEgps
RT @Ahmad_Taqi: Remdesivir for COVID-19. Single arm study, very difficult to make any conclusions from it, will have to wait on the ongoin…
RT @edgarvlermamd: Compassionate Use of Remdesivir for Patients with Severe #COVID19 ca. 2020 from @NEJM 👉🏼 https://t.co/LrPBo3tpSn https:…
RT @88549439: @VanRodrigues @JamesTodaroMD 60% patients had adverse events; 23% patients had serious adverse events. The safety profile of…
RT @CorinneReverbel: @NBCNews #remdesivir did'nt work and reported adverse events during follow-up https://t.co/Kt5GoRI98v https://t.co…
.@MSNBC #remdesivir . I tweeted this 3 weeks AGO. US sent it to china early Jan. why today are MSM presenting this old news as new news?
RT @edgarvlermamd: Compassionate Use of Remdesivir for Patients with Severe #COVID19 ca. 2020 from @NEJM 👉🏼 https://t.co/LrPBo3tpSn https:…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: I'm feeling better that the signal I called weeks ago from the 1st report panned out to be true, despite many who challenged…
RT @EricTopol: I'm feeling better that the signal I called weeks ago from the 1st report panned out to be true, despite many who challenged…
@sobotelha esse é promissor, mas ser promissor, o que não é certeza, longe disso, mas nesse se pode ter esperança concreta.
Artigo publicado no @NEJM : Uso compassivo de Remdesivir em pacientes com Covid-19 grave. Link: (+) https://t.co/V5CkVu1o2S
The remdesivir is not a silver bullet with a decisive effect. This is the range of medicinal effects that can be expected to have an improving effect. - Compassionate Use of Remdesivir for Patients with Severe Covid-19 | NEJM https://t.co/KKNm3EQiVu
Compassionate Use of Remdesivir for Patients with Severe Covid-19 | NEJM https://t.co/MpDqylt7sg
RT @rising_serpent: Patients hospitalized for severe Covid-19 who were treated with compassionate-use remdesivir, clinical improvement was…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @CorinneReverbel: @NBCNews #remdesivir did'nt work and reported adverse events during follow-up https://t.co/Kt5GoRI98v https://t.co…
RT @edgarvlermamd: Compassionate Use of Remdesivir for Patients with Severe #COVID19 ca. 2020 from @NEJM 👉🏼 https://t.co/LrPBo3tpSn https:…
Da gerade viel über #Remdesivir in den Medien berichtet wird, hier eine Studie zum nachlesen... Spoiler: es ist keine Wunderwaffe, aber es kann helfen, in dieser Studie zumindest zu 68% Compassionate Use of Remdesivir for Patients with Severe Covid-19. h
@AlJoyed تحدي الشركة يكمن في الحالات الشديدة و الحرجة، من ضمن النتائج المرتقبة في الطريق ستكون على الحالات المتوسطة... سبق و ان تمت تجربة الدواء على شريحة محدودة لمرضى كوفيد-١٩ بدرجة بسيطة و متوسطة و ابدى فاعلية -مبدئية- ممتازة كما في التغريدة المقتبسة ht
RT @CorinneReverbel: ATTENTION AUX ANNONCES DE GILEAD ➡️Ne pas oublier ce qui est publié sur Remdesivir dans NEJM ⚠️Toxicité du #Remdesivi…
RT @EricTopol: I'm feeling better that the signal I called weeks ago from the 1st report panned out to be true, despite many who challenged…
raoult ATTENTION AUX ANNONCES DE GILEAD Toxicité du Remdesivir pour les patients à qui il a été administré 60% d’effets secondaires 23% d’effets sec. graves 8% menant à l’arrêt du traitement https://t.co/7nGUabgRuj https://t.co/Jv2OHLOy3s
@VanRodrigues @JamesTodaroMD 60% patients had adverse events; 23% patients had serious adverse events. The safety profile of remdesivir doesn't look very good. Maybe the fatal side effects explain the no benefits in mortality, even though it has efficacy i
#raoult ATTENTION AUX ANNONCES DE GILEAD Toxicité du #Remdesivir pour les patients à qui il a été administré 60% d’effets secondaires 23% d’effets sec. graves 8% menant à l’arrêt du traitement https://t.co/dibmqtRjOt https://t.co/pt1ZDsud2y
RT @EricTopol: I'm feeling better that the signal I called weeks ago from the 1st report panned out to be true, despite many who challenged…
RT @CorinneReverbel: ATTENTION AUX ANNONCES DE GILEAD ➡️Ne pas oublier ce qui est publié sur Remdesivir dans NEJM ⚠️Toxicité du #Remdesivi…
RT @CorinneReverbel: ATTENTION AUX ANNONCES DE GILEAD ➡️Ne pas oublier ce qui est publié sur Remdesivir dans NEJM ⚠️Toxicité du #Remdesivi…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: I'm feeling better that the signal I called weeks ago from the 1st report panned out to be true, despite many who challenged…
RT @EricTopol: I'm feeling better that the signal I called weeks ago from the 1st report panned out to be true, despite many who challenged…
@kevindandy1 Not exactly new news but it’s all over the ‘Net today - https://t.co/T0KFsMAut4
RT @EricTopol: I'm feeling better that the signal I called weeks ago from the 1st report panned out to be true, despite many who challenged…
RT @kidney_boy: Ladies and gentleman, I think we have a therapy. https://t.co/QpN0tKFSfo https://t.co/WDCpgLwU0A
RT @EricTopol: I'm feeling better that the signal I called weeks ago from the 1st report panned out to be true, despite many who challenged…
RT @CorinneReverbel: @EricBillyFR Toxicité du #Remdesivir pour les patients à qui il a été administré  60% d’effets secondaires  23% d’ef…
@piersmorgan Hmmm. Reading the publicly available data on the "study" does not convince me. https://t.co/ICerDVTqSE
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: I'm feeling better that the signal I called weeks ago from the 1st report panned out to be true, despite many who challenged…
RT @EricTopol: I'm feeling better that the signal I called weeks ago from the 1st report panned out to be true, despite many who challenged…
RT @CorinneReverbel: @EricBillyFR Toxicité du #Remdesivir pour les patients à qui il a été administré  60% d’effets secondaires  23% d’ef…
RT @EricTopol: I'm feeling better that the signal I called weeks ago from the 1st report panned out to be true, despite many who challenged…
It would be great if these two papers were published in the same journal. The NEJM on April 10: Compassionate Use of #Remdesivir on #Covid-19. https://t.co/kkNKagtM4k The Lancet on April 29: #Remdesivir RCT trial on #COVID-19: https://t.co/71axvUlA7h
📗 Se publica un paper en NEJM en el cual se brinda Remdesivir como uso compasivo a 53 pacientes, de los cuales 36 mejoran. ¿qué significa eso en cuando a la eficacia? no lo sabemos pues este estudio no tuvo grupo comparador: https://t.co/tEMEKH6QCq
RT @EricTopol: I'm feeling better that the signal I called weeks ago from the 1st report panned out to be true, despite many who challenged…
RT @EricTopol: I'm feeling better that the signal I called weeks ago from the 1st report panned out to be true, despite many who challenged…
RT @YAYshamsaldeen: @SaraAl3jmi تحدي الشركة يكمن في الحالات الشديدة و الحرجة، من ضمن النتائج المرتقبة في الطريق ستكون على الحالات المتوسطة.…
@NBCNews #remdesivir did'nt work and reported adverse events during follow-up https://t.co/Kt5GoRI98v https://t.co/MIAhvLa1pg
RT @EricTopol: I'm feeling better that the signal I called weeks ago from the 1st report panned out to be true, despite many who challenged…
@dr_l_alexandre Phase grave: #Remdesivir marche pas https://t.co/Kt5GoRI98v + 23% des patients avec effets secondaires graves https://t.co/MIAhvLa1pg Phase très grave: #Tocilizumab oui avec beaucoup d'effets secondaires mais bénéfice/risque sans doute f
RT @CorinneReverbel: @EricBillyFR Toxicité du #Remdesivir pour les patients à qui il a été administré  60% d’effets secondaires  23% d’ef…
RT @EricTopol: I'm feeling better that the signal I called weeks ago from the 1st report panned out to be true, despite many who challenged…
RT @EricTopol: I'm feeling better that the signal I called weeks ago from the 1st report panned out to be true, despite many who challenged…
RT @EricTopol: I'm feeling better that the signal I called weeks ago from the 1st report panned out to be true, despite many who challenged…
@EricBillyFR Toxicité du #Remdesivir pour les patients à qui il a été administré  60% d’effets secondaires  23% d’effets sec. graves  8% menant à l’arrêt du traitement https://t.co/w9hZ7snwUU
RT @EricTopol: I'm feeling better that the signal I called weeks ago from the 1st report panned out to be true, despite many who challenged…
RT @EricTopol: I'm feeling better that the signal I called weeks ago from the 1st report panned out to be true, despite many who challenged…
RT @EricTopol: I'm feeling better that the signal I called weeks ago from the 1st report panned out to be true, despite many who challenged…
RT @EricTopol: I'm feeling better that the signal I called weeks ago from the 1st report panned out to be true, despite many who challenged…
RT @EricTopol: I'm feeling better that the signal I called weeks ago from the 1st report panned out to be true, despite many who challenged…
RT @EricTopol: I'm feeling better that the signal I called weeks ago from the 1st report panned out to be true, despite many who challenged…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: I'm feeling better that the signal I called weeks ago from the 1st report panned out to be true, despite many who challenged…
RT @EricTopol: I'm feeling better that the signal I called weeks ago from the 1st report panned out to be true, despite many who challenged…
RT @EricTopol: I'm feeling better that the signal I called weeks ago from the 1st report panned out to be true, despite many who challenged…
I'm feeling better that the signal I called weeks ago from the 1st report panned out to be true, despite many who challenged the call https://t.co/Bt8Ju1Z5ct
Compassionate Use of Remdesivir for Patients with Severe Covid-19 | NEJM https://t.co/uphCC7nG5Z
RT @CorinneReverbel: ATTENTION AUX ANNONCES DE GILEAD ➡️Ne pas oublier ce qui est publié sur Remdesivir dans NEJM ⚠️Toxicité du #Remdesivi…
RT @CorinneReverbel: ATTENTION AUX ANNONCES DE GILEAD ➡️Ne pas oublier ce qui est publié sur Remdesivir dans NEJM ⚠️Toxicité du #Remdesivi…
RT @CorinneReverbel: ATTENTION AUX ANNONCES DE GILEAD ➡️Ne pas oublier ce qui est publié sur Remdesivir dans NEJM ⚠️Toxicité du #Remdesivi…
RT @CorinneReverbel: ATTENTION AUX ANNONCES DE GILEAD ➡️Ne pas oublier ce qui est publié sur Remdesivir dans NEJM ⚠️Toxicité du #Remdesivi…
RT @CorinneReverbel: ATTENTION AUX ANNONCES DE GILEAD ➡️Ne pas oublier ce qui est publié sur Remdesivir dans NEJM ⚠️Toxicité du #Remdesivi…
RT @CorinneReverbel: ATTENTION AUX ANNONCES DE GILEAD ➡️Ne pas oublier ce qui est publié sur Remdesivir dans NEJM ⚠️Toxicité du #Remdesivi…
@Complexificator @DrDenaGrayson @NIH Source on the European and Dutch study. https://t.co/sKoY0k8zW4
@FoodFromEden @jimcramer True - although liver toxicity is well known due to extensive Ebola testing. The results my quote references is here: https://t.co/R56XYzFfJO
RT @CorinneReverbel: ATTENTION AUX ANNONCES DE GILEAD ➡️Ne pas oublier ce qui est publié sur Remdesivir dans NEJM ⚠️Toxicité du #Remdesivi…
RT @CorinneReverbel: ATTENTION AUX ANNONCES DE GILEAD ➡️Ne pas oublier ce qui est publié sur Remdesivir dans NEJM ⚠️Toxicité du #Remdesivi…
RT @CorinneReverbel: ATTENTION AUX ANNONCES DE GILEAD ➡️Ne pas oublier ce qui est publié sur Remdesivir dans NEJM ⚠️Toxicité du #Remdesivi…
RT @CorinneReverbel: ATTENTION AUX ANNONCES DE GILEAD ➡️Ne pas oublier ce qui est publié sur Remdesivir dans NEJM ⚠️Toxicité du #Remdesivi…
RT @CorinneReverbel: ATTENTION AUX ANNONCES DE GILEAD ➡️Ne pas oublier ce qui est publié sur Remdesivir dans NEJM ⚠️Toxicité du #Remdesivi…